SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Revolutions Medical Corp – ‘S-1’ on 4/18/14 – ‘R2’

On:  Friday, 4/18/14, at 5:15pm ET   ·   Accession #:  1437749-14-6872   ·   File #:  333-195393

Previous ‘S-1’:  ‘S-1/A’ on 7/19/13   ·   Next:  ‘S-1/A’ on 6/17/14   ·   Latest:  ‘S-1/A’ on 1/20/15

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/18/14  Revolutions Medical Corp          S-1                   63:12M                                    RDG Filings/FA

Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   2.25M 
 2: EX-23       Exhibit 23.1                                        HTML     21K 
40: R1          Document And Entity Information                     HTML     50K 
30: R2          Balance Sheets                                      HTML    106K 
38: R3          Balance Sheets (Parentheticals)                     HTML     45K 
43: R4          Statements of Operations                            HTML     90K 
58: R5          Statements of Stockholders’ Equity                  HTML    852K 
32: R6          Statements of Cash Flows                            HTML    147K 
37: R7          Note 1 - Basis of Presentation, Description of      HTML     86K 
                Business, Significant Accounting Policies,                       
                Critical Accounting Estimates and                                
                Reclassifications                                                
27: R8          Note 2 - Going Concern                              HTML     24K 
19: R9          Note 3 - Property And Equipment                     HTML     46K 
59: R10         Note 4 - Intangibles                                HTML     40K 
45: R11         Note 5 - Accounts Payable and Accrued Liabilities   HTML     47K 
44: R12         Note 7 - Payable for Indemnification                HTML     29K 
49: R13         Note 8 - Convertible Notes                          HTML    117K 
50: R14         Note 9 - Derivatives - Note Conversion Feature      HTML     74K 
48: R15         Note 10 - Commitments and Contingencies             HTML     56K 
51: R16         Note 11 - Preferred Stock and Common Stock          HTML     39K 
                Transactions                                                     
39: R17         Note 12 - Stock Options and Warrants Outstanding    HTML    118K 
42: R18         Note 13 - Related Party Transactions                HTML     42K 
47: R19         Note 14 - Subsequent Events                         HTML     24K 
63: R20         Accounting Policies, by Policy (Policies)           HTML    142K 
54: R21         Note 1 - Basis of Presentation, Description of      HTML     80K 
                Business, Significant Accounting Policies,                       
                Critical Accounting Estimates and                                
                Reclassifications (Tables)                                       
34: R22         Note 3 - Property And Equipment (Tables)            HTML     42K 
46: R23         Note 4 - Intangibles (Tables)                       HTML     34K 
36: R24         Note 5 - Accounts Payable and Accrued Liabilities   HTML     40K 
                (Tables)                                                         
14: R25         Note 8 - Convertible Notes (Tables)                 HTML     75K 
55: R26         Note 9 - Derivatives - Note Conversion Feature      HTML     78K 
                (Tables)                                                         
60: R27         Note 12 - Stock Options and Warrants Outstanding    HTML    110K 
                (Tables)                                                         
23: R28         Note 13 - Related Party Transactions (Tables)       HTML     35K 
22: R29         Note 1 - Basis of Presentation, Description of      HTML     35K 
                Business, Significant Accounting Policies,                       
                Critical Accounting Estimates and                                
                Reclassifications (Details)                                      
25: R30         Note 1 - Basis of Presentation, Description of      HTML     27K 
                Business, Significant Accounting Policies,                       
                Critical Accounting Estimates and                                
                Reclassifications (Details) - Estimated Useful                   
                Lives of Property Plant and Equipment                            
26: R31         Note 1 - Basis of Presentation, Description of      HTML     31K 
                Business, Significant Accounting Policies,                       
                Critical Accounting Estimates and                                
                Reclassifications (Details) - Fair Value, Assets                 
                and Liabilities Measured on Recurring Basis                      
28: R32         Note 2 - Going Concern (Details)                    HTML     34K 
13: R33         Note 3 - Property And Equipment (Details)           HTML     36K 
52: R34         Note 3 - Property And Equipment (Details) -         HTML     32K 
                Summary of Property And Equipment                                
33: R35         Note 4 - Intangibles (Details)                      HTML     27K 
35: R36         Note 4 - Intangibles (Details) - Summary of         HTML     28K 
                Intangible Assets                                                
17: R37         Note 5 - Accounts Payable and Accrued Liabilities   HTML     41K 
                (Details)                                                        
62: R38         Note 5 - Accounts Payable and Accrued Liabilities   HTML     41K 
                (Details) - Summary of Accounts Payable and                      
                Accrued Liabilities                                              
 9: R39         Note 7 - Payable for Indemnification (Details)      HTML     31K 
29: R40         Note 8 - Convertible Notes (Details)                HTML    296K 
57: R41         Note 8 - Convertible Notes (Details) - Notes        HTML     44K 
                Payable                                                          
16: R42         Note 8 - Convertible Notes (Details) - Notes        HTML     39K 
                Payable (Parentheticals)                                         
21: R43         Note 9 - Derivatives - Note Conversion Feature      HTML     32K 
                (Details) - Reconciliation of Derivative Liability               
24: R44         Note 9 - Derivatives - Note Conversion Feature      HTML     37K 
                (Details) - Fair Value Assumptions, Derivative                   
                Liability                                                        
31: R45         Note 10 - Commitments and Contingencies (Details)   HTML     91K 
12: R46         Note 11 - Preferred Stock and Common Stock          HTML    103K 
                Transactions (Details)                                           
18: R47         Note 12 - Stock Options and Warrants Outstanding    HTML     66K 
                (Details)                                                        
10: R48         Note 12 - Stock Options and Warrants Outstanding    HTML     72K 
                (Details) - Stock Options and Warrants Outstanding               
                Activities                                                       
56: R49         Note 13 - Related Party Transactions (Details)      HTML     47K 
15: R50         Note 13 - Related Party Transactions (Details) -    HTML     28K 
                Amounts Owed by the Company to its Executive                     
                Officers                                                         
53: R51         Note 14 - Subsequent Events (Details)               HTML     40K 
61: XML         IDEA XML File -- Filing Summary                      XML    102K 
11: EXCEL       IDEA Workbook of Financial Reports                  XLSX    221K 
20: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.05M 
 3: EX-101.INS  XBRL Instance -- rmcp-20131231                       XML   2.11M 
 5: EX-101.CAL  XBRL Calculations -- rmcp-20131231_cal               XML     99K 
 6: EX-101.DEF  XBRL Definitions -- rmcp-20131231_def                XML    979K 
 7: EX-101.LAB  XBRL Labels -- rmcp-20131231_lab                     XML   1.47M 
 8: EX-101.PRE  XBRL Presentations -- rmcp-20131231_pre              XML    924K 
 4: EX-101.SCH  XBRL Schema -- rmcp-20131231                         XSD    238K 
41: ZIP         XBRL Zipped Folder -- 0001437749-14-006872-xbrl      Zip    190K

‘R2’   —   Balance Sheets

This is an IDEA Financial Report.  [ Alternative Formats ]

 
v2.4.0.8
Balance Sheets (USD $)
Current Assets:    
Cash and cash equivalents $ 932 $ 54
Inventory 278,564 321,791
Prepaid expenses and other current assets 2,932 4,859
Total current assets 282,428 326,704
Property and equipment, net 270,189 356,656
Intangibles, net 133,517 106,687
Total assets 686,134 790,047
Accounts payable and accrued liabilities 1,867,192 1,122,371
Accounts payable and accrued liabilities, related parties 132,407 73,957
Unearned revenue 73,495  
Payable for indemnification 1,376,084 1,347,806
Convertible notes, net of discounts of $247,661 and $187,039, respectively 494,708 184,289
Convertible notes, related parties, net of discounts of $0 and $42,534, respectively 75,000 32,466
Derivative liability, note conversion feature 658,453 364,802
Total liabilities 7,924,434 4,406,551
Commitments and contingencies      
Stockholders' deficit:    
Series 2006 Preferred stock, $0.001 par value, 5,000,000 shares authorized; 1,000,000 shares issued and outstanding 1,000 1,000
Common stock, $0.001 par value; 250,000,000 shares authorized; 107,039,034 and 72,784,907 shares issued and outstanding, respectively 107,039 72,785
Additional paid-in-capital 37,087,921 34,319,432
Subscriptions receivable (71,000) (71,000)
Deficit accumulated during the development stage (44,363,260) (37,938,721)
Total stockholders' deficit (7,238,300) (3,616,504)
Total liabilities and stockholders' deficit 686,134 790,047
Yeso Med [Member]
    
Current Assets:    
Payable to Yeso-med $ 3,247,095 $ 1,280,860

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1’ Filing    Date    Other Filings
Filed on:4/18/14
12/31/1310-K,  NT 10-K
12/31/1210-K,  10-K/A,  NT 10-K
 List all Filings 
↑Top
Filing Submission 0001437749-14-006872   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., May 12, 1:18:49.1pm ET